Results 191 to 200 of about 104,680 (275)

High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development. [PDF]

J Biol Chem
Van den Ackerveken P, Hannart C, Pamart D, Varsebroucq R, Wargnies M, Thiry O, Lurkin M, Vincent S, Chapelier M, Rommelaere G, Herzog M.   +10 more
europepmc   +1 more source

He Who Controls the Mind Controls the Body: False Imprisonment, Religious Cults, and the Destruction of Volitional Capacity [PDF]

, 2011
Brown, Laura B.
core   +2 more sources

Market potential of biobased chemicals: a qualitative network analysis of adoption dynamics in South Africa’s bioeconomy

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree, George Alex Thopil, Santosh Ramchuran   +2 more
wiley   +1 more source

Capturing Land for Elephant Corridors in South India through the Conservation-Agrarian Squeeze. [PDF]

Environ Manage
Siddhartha A.
europepmc   +1 more source

From prescription to volition [PDF]

, 2014
Hallward, Peter
core  

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

An interprofessional education program based on the ARCS-V motivation model on the theme of "Chronic Disease Management and Patient Safety": action research. [PDF]

BMC Med Educ
Başer A, Şahin H.
europepmc   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test. [PDF]

Cancers (Basel)
Chen PH, Tsai TM, Lu TP, Lu HH, Pamart D, Kotronoulas A, Herzog M, Micallef JV, Hsu HH, Chen JS.   +9 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source